---
document_datetime: 2023-09-21 18:39:58
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/neupopeg-epar-all-authorised-presentations_en.pdf
document_name: neupopeg-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3444584
conversion_datetime: 2025-12-15 01:53:26.393361
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
EU Number

EU/1/02/228/001

EU/1/02/228/002

EU/1/02/228/003

Invented name

Neupopeg

Neupopeg

Neupopeg

Strength

6 mg

6 mg

6 mg

Pharmaceutical

Form

Solution for injection

Solution for injection

Solution for injection

Route of

Administration

Subcutaneous use

Subcutaneous use

Subcutaneous use

Packaging pre-filled

syringe (glass)

pre-filled syringe (glass)

without blister pre-filled pen

(glass)

(SureClick)

Content

0.6 ml (10 mg/ml)

0.6 ml (10 mg/ml)

0.6 ml (10 mg/ml)

Package size

1 pre-filled syringe

1 pre-filled syringe

1 pre-filled pen

Medicinal product no longer authorised